-
Saying preventing health care associated infections (HAIs) is a national priority, the federal Agency for Healthcare Research and Quality (AHRQ) is putting considerable money where its mouth is: $34 million.
-
The U.S. Occupational Safety and Health Administration may be becoming more cautious in its push for new regulations that include a standard on infectious diseases.
-
In this issue: Escitalopram for menopausal hot flashes, rifaximin for IBS without constipation, herpes zoster vaccination, antiepileptics drugs and fracture risk, and FDA Actions.
-
To investigate the natural history of alcohol intake in women after age 50, two randomly sampled, nationally representative large cohorts of older women initially between the ages of 50 and 65 were followed with biannual questionnaires for concurrent 8-10 year periods.
-
Two cases were reported in this paper. the first case was a 52-year-old wildlife biologist who went deer hunting in Virginia in November 2008.
-
In this study, 2,499 hiv-seronegative men or transgender females who have sex with men (MSM) were randomized to daily TDF/FTC vs. placebo in a multicenter, controlled trial with clinical sites in North America, Latin America, Thailand, and Africa.
-
More health care workers responded to this season's push for influenza vaccination by rolling up their sleeves and getting the vaccine.
-
When it comes to MRSA infection control in the chaotic emergency department (ED), enhanced attention to standard precautions and hand hygiene is a more cost-effective approach than active screening cultures, researchers report.
-
The national epidemic of Clostridium difficile is moving into the pediatric population, causing infections in children that prolong hospitalizations, increase morbidity and spell a striking increase in the risk of death.
-
Group B streptococcal (GBS) disease is the leading cause of early-onset neonatal sepsis (within the first week of life) in the United States. Since the initial recommendations for perinatal prophylaxis in the 1990s, the incidence of GBS has declined by 80%.